Week in review: Sustained gains, Restasis tribunal, O’Keeffe eyepiece
- Posted on: Apr 19 2019
- Leave a response
This week, a gene therapy for Leber hereditary optic neuropathy provides a sustained vision boost, the Supreme Court blocks Allergan’s bid to shield Restasis from generic competition and a partnership between the Georgia O’Keeffe museum and EnChroma could help colorblind art enthusiasts experience a new level of vibrancy.
Source: AAO
Posted in: Uncategorized
